PTCT 8-K 2026-09-21
PTC THERAPEUTICS, INC. (PTCT) 8-K dated 2026-09-21 — accession 0001070081-26-000023.
PTC THERAPEUTICS, INC. (PTCT) is a biotechnology company listed on NASDAQ.
PTC THERAPEUTICS, INC. filed a 8-K on 2026-09-21. Accession 0001070081-26-000023.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PTCT revenue for 2025-12-31 was $1.73B. Net income was $682.6M. Revenue was up 114.5% from 2024-12-31 to 2025-12-31. PTCT currently screens at market cap $6.51B.
Not investment advice. The PTCT SEC hub lists recent forms. The stock page is the research view.